IMCY-0098
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IMCY-0098, covering 2022-01-21 to 2024-06-24. Get the full timeline:
Most recent: Clinical Trial Update: IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) [Phase 2]